Join
Live feed
·
SECFilingvia Quantisnow
Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation filed SEC Form 8-K: Termination of a Material Definitive Agreement, Leadership Update, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
ABUS· Arbutus Biopharma Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABUS (Arbutus Biopharma Corporation) and more on Quantisnow.

Arbutus Biopharma Corporation filed SEC Form 8-K: Termination of a Material Definitive Agreement, Leadership Update, Other Events, Financial Statements and Exhibits | Quantisnow